<- Go Home

Johnson & Johnson Surgical Vision, Inc.

Johnson & Johnson Surgical Vision, Inc. offers ophthalmic products for cataract and laser refractive surgery. It offers surgical systems that include precision laser system; phacoemulsification systems and accessories including foot pedals, handpieces, and phacoemulsification packs; compact intuitive system; advanced femtosecond laser; excimer laser; advanced wave scan studio system; and StabilEyes capsular tension ring. It also provides ophthalmic viscoelastic devices and intraocular lens that includes multi-focal, toric, and mono-focal lens, and implants. Johnson & Johnson Surgical Vision, Inc. was formerly known as Abbott Medical Optics Inc. and changed its name to Johnson & Johnson Surgical Vision, Inc. in February 2017. The company was founded in 1976 and is based in Jacksonville, Florida. Johnson & Johnson Surgical Vision, Inc. operates as a subsidiary of Johnson & Johnson.

Market Cap

$1.4B

Volume

1.0M

Cash and Equivalents

$50.7M

EBITDA

$269.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$722.2M

Profit Margin

60.94%

52 Week High

$24.90

52 Week Low

$2.88

Dividend

N/A

Price / Book Value

2.12

Price / Earnings

22.66

Price / Tangible Book Value

-1.21

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$154.8M

Return on Equity

9.86%

Return on Assets

3.66

Cash and Short Term Investments

$50.7M

Debt

$1.4B

Equity

$639.6M

Revenue

$1.2B

Unlevered FCF

$172.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches